Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Urinary Bladder Neoplasms 41Non-Muscle Invasive Bladder Neoplasms 25Colorectal Neoplasms 20Anus Neoplasms 17Carcinoma, Transitional Cell 15Neoplasm Metastasis 12Carcinoma, Hepatocellular 10Appendiceal Neoplasms 10Stomach Neoplasms 9Peritoneal Neoplasms 9Pancreatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Neoplasms 6Lung Neoplasms 6Colonic Neoplasms 6Rectal Neoplasms 5Liver Neoplasms 5Sarcoma 4Anal Canal Carcinoma 4Urologic Neoplasms 3Urologic Diseases 3Urinary Bladder Diseases 3Pseudomyxoma Peritonei 3Mesothelioma, Malignant 3Gastrointestinal Neoplasms 3Carcinoma in Situ 3Carcinoma 3Breast Neoplasms 3Urogenital Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2

Interventions

Cyclophosphamide 344Cytarabine 281fludarabine phosphate 201Methotrexate 185Filgrastim 159Busulfan 147Etoposide 135Peripheral Blood Stem Cell Transplantation 133fludarabine 127Rituximab 119Radiotherapy 111Vincristine 102Cyclosporine 98Daunorubicin 96Antilymphocyte Serum 94Dexamethasone 91Tacrolimus 85Mycophenolic Acid 85Whole-Body Irradiation 80Melphalan 79Idarubicin 67Mercaptopurine 66Imatinib Mesylate 66Granulocyte Colony-Stimulating Factor 65Azacitidine 65Methylprednisolone 59Prednisone 58Doxorubicin 58Clofarabine 54sargramostim 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Leukemia × Mitomycin × Clear all
NCT00003003 2018-03-19

Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
29 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡